Patient engagement with antibiotic messaging in secondary care: a qualitative feasibility study of the 'review and revise' experience.

Antibiotic prescribing Antimicrobial stewardship Hospital patients

Journal

Pilot and feasibility studies
ISSN: 2055-5784
Titre abrégé: Pilot Feasibility Stud
Pays: England
ID NLM: 101676536

Informations de publication

Date de publication:
2020
Historique:
received: 18 06 2019
accepted: 24 03 2020
entrez: 14 4 2020
pubmed: 14 4 2020
medline: 14 4 2020
Statut: epublish

Résumé

We aimed to investigate and optimise the acceptability and usefulness of a patient leaflet about antibiotic prescribing decisions made during hospitalisation, and to explore individual patient experiences and preferences regarding the process of antibiotic prescription 'review and revise' which is a key strategy to minimise antibiotic overuse in hospitals. In this qualitative study, run within the feasibility study of a large, cluster-randomised stepped wedge trial of 36 hospital organisations, a series of semi-structured, think-aloud telephone interviews were conducted and data were analysed using thematic analysis. Fifteen adult patients who had experienced a recent acute medical hospital admission during which they had been prescribed antimicrobials and offered a patient leaflet about antibiotic prescribing were recruited to the study. Participants reacted positively to the leaflet, reporting that it was both an accessible and important source of information which struck the appropriate balance between informing and reassuring. Participants all valued open communication with clinicians, and were keen to be involved in antibiotic prescribing decisions, with individuals reporting positive experiences regarding antibiotic prescription changes or stopping. Many participants had prior experience or knowledge of antibiotics and resistance, and generally welcomed efforts to reduce antibiotic usage. Overall, there was a feeling that healthcare professionals (HCPs) are trusted experts providing the most appropriate treatment for individual patient conditions. This study offers novel insights into how patients within secondary care are likely to respond to messages advocating a reduction in the use of antibiotics through the 'review and revise' approach. Due to the level of trust that patients place in their care provider, encouraging HCPs within secondary care to engage patients with greater communication and information provision could provide great advantages in the drive to reduce antibiotic use. It may also be beneficial for HCPs to view patient experiences as cumulative events that have the potential to impact future behaviour around antibiotic use. Finally, pre-testing messages about antibiotic prescribing and resistance is vital to dispelling any misconceptions either around effectiveness of treatment for patients, or perceptions of how messages may be received. Current Controlled Trials ISRCTN12674243 (10 April 2017).

Sections du résumé

BACKGROUND BACKGROUND
We aimed to investigate and optimise the acceptability and usefulness of a patient leaflet about antibiotic prescribing decisions made during hospitalisation, and to explore individual patient experiences and preferences regarding the process of antibiotic prescription 'review and revise' which is a key strategy to minimise antibiotic overuse in hospitals.
METHODS METHODS
In this qualitative study, run within the feasibility study of a large, cluster-randomised stepped wedge trial of 36 hospital organisations, a series of semi-structured, think-aloud telephone interviews were conducted and data were analysed using thematic analysis. Fifteen adult patients who had experienced a recent acute medical hospital admission during which they had been prescribed antimicrobials and offered a patient leaflet about antibiotic prescribing were recruited to the study.
RESULTS RESULTS
Participants reacted positively to the leaflet, reporting that it was both an accessible and important source of information which struck the appropriate balance between informing and reassuring. Participants all valued open communication with clinicians, and were keen to be involved in antibiotic prescribing decisions, with individuals reporting positive experiences regarding antibiotic prescription changes or stopping. Many participants had prior experience or knowledge of antibiotics and resistance, and generally welcomed efforts to reduce antibiotic usage. Overall, there was a feeling that healthcare professionals (HCPs) are trusted experts providing the most appropriate treatment for individual patient conditions.
CONCLUSIONS CONCLUSIONS
This study offers novel insights into how patients within secondary care are likely to respond to messages advocating a reduction in the use of antibiotics through the 'review and revise' approach. Due to the level of trust that patients place in their care provider, encouraging HCPs within secondary care to engage patients with greater communication and information provision could provide great advantages in the drive to reduce antibiotic use. It may also be beneficial for HCPs to view patient experiences as cumulative events that have the potential to impact future behaviour around antibiotic use. Finally, pre-testing messages about antibiotic prescribing and resistance is vital to dispelling any misconceptions either around effectiveness of treatment for patients, or perceptions of how messages may be received.
TRIAL REGISTRATION BACKGROUND
Current Controlled Trials ISRCTN12674243 (10 April 2017).

Identifiants

pubmed: 32280483
doi: 10.1186/s40814-020-00590-5
pii: 590
pmc: PMC7126355
doi:

Types de publication

Journal Article

Langues

eng

Pagination

43

Subventions

Organisme : Department of Health
ID : RP-PG-0514-20015
Pays : United Kingdom

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsAll the authors declare no conflict of interest.

Références

JAMA. 2011 Mar 9;305(10):1027-8
pubmed: 21343545
BMJ. 2014 Mar 06;348:g1606
pubmed: 24603565
PLoS One. 2014 Sep 10;9(9):e106844
pubmed: 25208074
JAMA Intern Med. 2014 May;174(5):661-2
pubmed: 24595627
Clin Infect Dis. 2013 Jul;57(2):188-96
pubmed: 23572483
BMJ. 1997 Mar 8;314(7082):722-7
pubmed: 9116551
BMJ. 2012 Feb 02;344:d8173
pubmed: 22302780
Int J Clin Pharm. 2014 Jun;36(3):657-66
pubmed: 24777838
Antimicrob Resist Infect Control. 2018 Mar 20;7:43
pubmed: 29568516
Implement Sci. 2013 Nov 15;8:134
pubmed: 24238118
Arch Intern Med. 2003 Apr 28;163(8):972-8
pubmed: 12719208
J Antimicrob Chemother. 2012 Jul;67 Suppl 1:i51-63
pubmed: 22855879
BMJ. 2017 Jul 26;358:j3418
pubmed: 28747365
PLoS One. 2018 May 3;13(5):e0196868
pubmed: 29723262
Clin Microbiol Infect. 2019 Feb;25(2):249.e7-249.e12
pubmed: 29777924
J Antimicrob Chemother. 2016 Jan;71(1):27-33
pubmed: 26459555
J Gen Intern Med. 2012 Jul;27(7):766-72
pubmed: 22065334
Euro Surveill. 2018 Jun;23(25):
pubmed: 29945699
BMJ. 1997 Aug 9;315(7104):350-2
pubmed: 9270458
Cochrane Database Syst Rev. 2015 Nov 12;(11):CD010907
pubmed: 26560888
J Antimicrob Chemother. 2015 Apr;70(4):1230-5
pubmed: 25538165
Am J Infect Control. 2013 Nov;41(11):955-8
pubmed: 23870794
J Antimicrob Chemother. 2019 Nov 1;74(11):3362-3370
pubmed: 31430366
Infect Control Hosp Epidemiol. 2016 May;37(5):576-82
pubmed: 26809477
J Med Internet Res. 2015 Jan 30;17(1):e30
pubmed: 25639757
MMWR Morb Mortal Wkly Rep. 2014 Mar 7;63(9):194-200
pubmed: 24598596
JAMA Intern Med. 2016 Sep 1;176(9):1254-5
pubmed: 27455385
BMJ Open. 2016 Oct 31;6(10):e011040
pubmed: 27799238
Cochrane Database Syst Rev. 2017 Feb 09;2:CD003543
pubmed: 28178770
Trials. 2019 Jul 11;20(1):421
pubmed: 31296255
J Cancer Surviv. 2013 Dec;7(4):592-601
pubmed: 23892559
J Hosp Infect. 2019 Nov;103(3):268-275
pubmed: 31394146
Qual Health Res. 2010 Apr;20(4):565-75
pubmed: 19959822

Auteurs

Fiona Mowbray (F)

1Centre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.

Katy Sivyer (K)

1Centre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.

Marta Santillo (M)

1Centre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.

Nicola Jones (N)

2Nuffield Department of Medicine, University of Oxford, Oxford, UK.
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Tim E A Peto (TEA)

2Nuffield Department of Medicine, University of Oxford, Oxford, UK.
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

A Sarah Walker (AS)

2Nuffield Department of Medicine, University of Oxford, Oxford, UK.
3Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Martin J Llewelyn (MJ)

4Brighton and Sussex Medical School, Falmer, UK.

Lucy Yardley (L)

1Centre for Clinical and Community Applications of Health Psychology, University of Southampton, Southampton, UK.

Classifications MeSH